標題：Anti-Semaglutide (GLP-1 analogue) Polyclonal antibody抗體,AntibodySystem Laboratories：
鏈接：https://www.antibodysystem.com/product/17748.html
名稱：Anti-Semaglutide (GLP-1 analogue) Polyclonal antibody抗體
別名：Sermaglutide, Semaglutide fandachem, Semaglutide impurity, Sermaglutide USP/EP/BP, semaglutide, Sermaglutide
貨號：PHK13901
宿主：Rabbit
適用物種：Human
免疫原：Synthesized Semaglutide (GLP-1 analogue) conjugated with Carrier protein.
存儲緩沖區(qū)：PBS, pH 7.4, containing 0.05% proclin 300, 50% glycerol.
形式：Liquid
濃度：1.28 mg/ml
克?。?/b>Polyclonal
同型：IgG
應(yīng)用：WB, IHC, ELISA
CAS：910463-68-2
用途范圍：僅用于科研
儲存：Use a manual defrost freezer and avoid repeated freeze thaw cycles.Store at 4°C for frequent use.Store at -20 to -80 °C for twelve months from the date of receipt.
產(chǎn)品購買聯(lián)系方式：027-65279366 /18162686757
郵箱：biolab-reagents@atagenix.com
QQ：2663991332
參考文獻：
Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide. PMID: 26308095
GLP-1 receptor agonists in the treatment of type 2 diabetes - state-of-the-art. PMID: 33068776
GLP-1 receptor agonists and cardiovascular outcome trials: An update. PMID: 30528435
Comparative effectiveness of GLP-1 receptor agonists on glycaemic control, body weight, and lipid profile for type 2 diabetes: systematic review and network meta-analysis. PMID: 38286487
Oral GLP-1 analogue: perspectives and impact on atherosclerosis in type 2 diabetic patients. PMID: 34911560
Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer's disease: study protocol for a randomised controlled trial (ELAD study). PMID: 30944040
Update on the effects of GLP-1 receptor agonists for the treatment of polycystic ovary syndrome. PMID: 34015974
Safety and tolerability of once-weekly GLP-1 receptor agonists in type 2 diabetes. PMID: 32910487
A GIPR antagonist conjugated to GLP-1 analogues promotes weight loss with improved metabolic parameters in preclinical and phase 1 settings. PMID: 38316982
Safety of GLP-1 Receptor Agonists and Other Second-Line Antidiabetics in Early Pregnancy. PMID: 38079178
Glucagon-like peptide-1 receptor co-agonists for treating metabolic disease. PMID: 32987188
The Antidepressant Effects of GLP-1 Receptor Agonists: A Systematic Review and Meta-Analysis. PMID: 37684186
Pharmacokinetics and Clinical Implications of Semaglutide: A New Glucagon-Like Peptide (GLP)-1 Receptor Agonist. PMID: 29915923
Estimated Lifetime Cardiovascular, Kidney, and Mortality Benefits of Combination Treatment With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Nonsteroidal MRA Compared With Conventional Care in Patients With Type 2 Diabetes and Albuminuria. PMID: 37952217
Risk of Gastrointestinal Adverse Events Associated With Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss. PMID: 37796527
Semaglutide (Ozempic) for weight loss. PMID: 33830968
Glucagon-like peptide 1 receptor agonists in type 1 diabetes mellitus. PMID: 31612934
Regurgitation under anesthesia in a fasted patient prescribed semaglutide for weight loss: a case report. PMID: 37280458
Glucagon-like peptide-1 receptor agonists in type 2 diabetes treatment: are they all the same? PMID: 30156747
A new era for oral peptides: SNAC and the development of oral semaglutide for the treatment of type 2 diabetes. PMID: 35838946
Liraglutide and obesity: a review of the data so far. PMID: 25848222
Glucagon-Like Peptide-1 Receptor Agonists Across the Spectrum of Heart Failure. PMID: 37409733
Effects of once-weekly semaglutide on appetite, energy intake, control of eating, food preference and body weight in subjects with obesity. PMID: 28266779
The association between glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and suicidality: reports to the Food and Drug Administration Adverse Event Reporting System (FAERS). PMID: 38087976
GLP-1 Receptor Agonists and Colorectal Cancer Risk in Drug-Naive Patients With Type 2 Diabetes, With and Without Overweight/Obesity. PMID: 38060218
GLP-1 as a target for therapeutic intervention. PMID: 27591964
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. PMID: 37952131
Oral Semaglutide: A Review of the First Oral Glucagon-Like Peptide 1 Receptor Agonist. PMID: 31436480
The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. PMID: 17098089
GLP-1 analogue therapy for obesity in people from Asia. PMID: 38330985
The Effect of GLP-1 Receptor Agonists on Postprandial Lipaemia. PMID: 35080714
Efficacy and safety of semaglutide for weight management: evidence from the STEP program. PMID: 36691309
The Future of the GLP-1 Receptor Agonists. PMID: 30903797
